These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3400981

  • 1. An automated method for the kinetic measurement of ferroxidase activity.
    Winkles J, Jones AF, Winyard P, Blake DR, Lunec J.
    Ann Clin Biochem; 1988 May; 25 ( Pt 3)():250-4. PubMed ID: 3400981
    [Abstract] [Full Text] [Related]

  • 2. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease.
    Evans PJ, Bomford A, Halliwell B.
    Free Radic Res Commun; 1989 May; 7(1):55-62. PubMed ID: 2806955
    [Abstract] [Full Text] [Related]

  • 3. Automated measurement of serum ferroxidase activity.
    Erel O.
    Clin Chem; 1998 Nov; 44(11):2313-9. PubMed ID: 9799759
    [Abstract] [Full Text] [Related]

  • 4. A New Kinetic, Automated Assay to Determine the Ferroxidase Activity of Ceruloplasmin.
    Neselioglu S, Ergin M, Erel O.
    Anal Sci; 2017 Nov; 33(12):1339-1344. PubMed ID: 29225221
    [Abstract] [Full Text] [Related]

  • 5. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.
    Wolf TL, Kotun J, Meador-Woodruff JH.
    Schizophr Res; 2006 Sep; 86(1-3):167-71. PubMed ID: 16842975
    [Abstract] [Full Text] [Related]

  • 6. Iron ion induced haemolysis: effect of caeruloplasmin, albumin and ascorbate (vitamin C).
    Løvstad RA.
    Int J Biochem; 1983 Sep; 15(8):1067-71. PubMed ID: 6617951
    [Abstract] [Full Text] [Related]

  • 7. The ferroxidase activity of caeruloplasmin is reduced in haemodialysis patients.
    Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS.
    Nephron; 2000 Mar; 84(3):211-7. PubMed ID: 10720890
    [Abstract] [Full Text] [Related]

  • 8. [Pre-steady state kinetics of the ferroxidase reaction catalyzed by ceruloplasmin].
    Siverina OB, Saenko EL, Basevich VV, Iaropolov AI.
    Biokhimiia; 1987 Jul; 52(7):1169-73. PubMed ID: 3663755
    [Abstract] [Full Text] [Related]

  • 9. Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation.
    Boyett JD, Lehmann HP, Beeler MF.
    Clin Chim Acta; 1976 Jun 01; 69(2):233-41. PubMed ID: 1277556
    [Abstract] [Full Text] [Related]

  • 10. The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper.
    Gutteridge JM, Winyard PG, Blake DR, Lunec J, Brailsford S, Halliwell B.
    Biochem J; 1985 Sep 01; 230(2):517-23. PubMed ID: 4052055
    [Abstract] [Full Text] [Related]

  • 11. A kinetic method amenable to automation for ceruloplasmin estimation with inexpensive and stable reagents.
    Somani BL, Ambade V.
    Clin Biochem; 2007 May 01; 40(8):571-4. PubMed ID: 17367772
    [Abstract] [Full Text] [Related]

  • 12. Ferrous binding to the multicopper oxidases Saccharomyces cerevisiae Fet3p and human ceruloplasmin: contributions to ferroxidase activity.
    Quintanar L, Gebhard M, Wang TP, Kosman DJ, Solomon EI.
    J Am Chem Soc; 2004 Jun 02; 126(21):6579-89. PubMed ID: 15161286
    [Abstract] [Full Text] [Related]

  • 13. Caeruloplasmin: a plasma protein, enzyme, and antioxidant.
    Gutteridge JM.
    Ann Clin Biochem; 1978 Nov 02; 15(6):293-6. PubMed ID: 736489
    [Abstract] [Full Text] [Related]

  • 14. Carbamylation inhibits the ferroxidase activity of caeruloplasmin.
    Roxborough HE, Millar CA, McEneny J, Young IS.
    Biochem Biophys Res Commun; 1995 Sep 25; 214(3):1073-8. PubMed ID: 7575512
    [Abstract] [Full Text] [Related]

  • 15. Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patients.
    Blake DR, Blann A, Bacon PA, Farr M, Gutteridge JM, Halliwell B.
    Clin Sci (Lond); 1983 May 25; 64(5):551-3. PubMed ID: 6403279
    [Abstract] [Full Text] [Related]

  • 16. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material.
    Swain J, Gutteridge JM.
    FEBS Lett; 1995 Jul 24; 368(3):513-5. PubMed ID: 7635210
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ferroxidase activity of ferritin: effects of pH, buffer and Fe(II) and Fe(III) concentrations on Fe(II) autoxidation and ferroxidation.
    Yang X, Chasteen ND.
    Biochem J; 1999 Mar 15; 338 ( Pt 3)(Pt 3):615-8. PubMed ID: 10051430
    [Abstract] [Full Text] [Related]

  • 20. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis.
    Swain JA, Darley-Usmar V, Gutteridge JM.
    FEBS Lett; 1994 Mar 28; 342(1):49-52. PubMed ID: 8143848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.